Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioavailability Study of Stiripentol After Single Oral Administration of Two Different Formulations (Capsule and Oral Suspension) in 24 Healthy Subjects

NCT07176832 is registered in ClinicalTrials.gov with Biocodex as lead sponsor.

NCT NCT07176832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07176832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioavailability Study of Stiripentol After Single Oral Administration of Two Different Formulations (Capsule and Oral Suspension) in 24 Healthy Subjects
Lead sponsor
Biocodex
Phase
Phase 1
Overall status
Completed
Start date
June 1, 2025
Completion date
August 27, 2025
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

childhood, dravet syndrome, epilepsy, epileptic encephalopathy, pediatric epilepsy